{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:51:35Z","timestamp":1792525895698,"version":"4.5.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"HORIZON EUROPE Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Leishmania<\/jats:italic>\n                      parasites cause neglected tropical diseases such as cutaneous and visceral leishmaniasis, which have limited treatment options and rising drug resistance. Protein kinases are pivotal in\n                      <jats:italic>Leishmania<\/jats:italic>\n                      biology and attractive drug targets, but their functional status in the parasite remains largely unexplored.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We applied activity-based protein profiling (ABPP) with custom in-house cell-permeable ATP-site directed probes to map the ligandable, \u201cactive kinome\u201d of\n                      <jats:italic>Leishmania mexicana<\/jats:italic>\n                      . Three related covalent probes featuring an ATP-mimetic scaffold, electrophilic warhead (targeting catalytic lysines or cysteines), and alkyne tag were synthesised to broadly capture active kinases. Live parasites were labelled with probes, followed by click-chemistry tagging, in-gel fluorescence, and tandem mass tag (TMT) proteomics for kinase identification and quantification. Comparative profiling was performed across\n                      <jats:italic>Leishmania<\/jats:italic>\n                      species and life stages. Key findings were validated by competition experiments with ibrutinib and parasite viability assays.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We uncovered 16 metabolic kinases and 32 protein kinases spanning all major kinase families (CMGC, AGC, STE, CAMK, CK1, and NEK), including nine protein kinase enzymes encoded by essential genes and several kinases lacking human orthologs. Notable hits included CRK1, MPK4, CK1.2, and an atypical kinase, underscoring their potential as drug targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study provides the first ABPP survey of the\n                      <jats:italic>Leishmania<\/jats:italic>\n                      kinome, revealing multiple ligandable, active kinases that drive parasite survival and virulence. Our chemoproteomic approach highlights both essential protein kinases and unique metabolic kinases as a rich source of potential drug targets. These findings demonstrate that ABPP can unveil the biochemically active kinases in\n                      <jats:italic>Leishmania<\/jats:italic>\n                      , offering a new strategy for prioritizing kinase targets and accelerating kinase inhibitor development against leishmaniasis. The work lays a foundation for next-generation antileishmanial therapies directed at the parasite kinome, particularly those kinases indispensable for the parasite yet sufficiently divergent from the human host.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1687590","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:43:26Z","timestamp":1767681806000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Activity-based chemoproteomic profiling reveals the active kinome of Leishmania"],"prefix":"10.3389","volume":"16","author":[{"given":"Exequiel O. J.","family":"Porta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karunakaran","family":"Kalesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.ijpara.2006.06.013","article-title":"Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro","volume":"36","author":"Allocco","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"102247","DOI":"10.1016\/j.jbc.2022.102247","article-title":"Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors","volume":"298","author":"Arter","year":"2022","journal-title":"J. Biol. Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nature18002","article-title":"Proteome-wide covalent ligand discovery in native biological systems","volume":"534","author":"Backus","year":"2016","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/s41467-021-21360-8","article-title":"Systematic functional analysis of leishmania protein kinases identifies regulators of differentiation or survival","volume":"12","author":"Baker","year":"2021","journal-title":"Nat. Comm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"122844","DOI":"10.1016\/j.lfs.2024.122844","article-title":"Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting leishmania MAP kinases","volume":"351","author":"Bhattacharjee","year":"2024","journal-title":"Life Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.pt.2012.05.005","article-title":"Purine salvage in Leishmania: complex or simple by design?","volume":"28","author":"Boitz","year":"2012","journal-title":"Trends Parasitol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.csbj.2019.02.005","article-title":"Unveiling the kinomes of Leishmania infantum and L. braziliensis empowers the discovery of new kinase targets and antileishmanial compounds","volume":"17","author":"Borba","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1004347","DOI":"10.1371\/journal.ppat.1004347","article-title":"Transgenic analysis of the Leishmania MAP kinase MPK10 reveals an auto-inhibitory mechanism crucial for stage-regulated activity and parasite viability","volume":"10","author":"Cayla","year":"2014","journal-title":"PLoS Pathog."},{"key":"B9","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.pt.2022.08.009","article-title":"Distinguishing functions of trypanosomatid protein kinases","volume":"38","author":"Cayla","year":"2022","journal-title":"Trends Parasitol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"100296","DOI":"10.1016\/j.cobme.2021.100296","article-title":"Advances in activity-based diagnostics for infectious disease and microbiome health","volume":"19","author":"Chan","year":"2021","journal-title":"Curr. Opin. Biomed"},{"key":"B11","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/21645515.2019.1678998","article-title":"Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis","volume":"16","author":"Coutinho de Oliveira","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1021\/pr101065j","article-title":"Andromeda: a peptide search engine integrated into the MaxQuant environment","volume":"10","author":"Cox","year":"2011","journal-title":"J. Proteome Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e79287","DOI":"10.1371\/journal.pone.0079287","article-title":"Identification of a secreted casein kinase 1 in Leishmania donovani: effect of protein over expression on parasite growth and virulence","volume":"8","author":"Dan-Goor","year":"2013","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2217\/fon.14.51","article-title":"Ibrutinib: a first in class covalent inhibitor of Bruton's tyrosine kinase","volume":"10","author":"Davids","year":"2014","journal-title":"Future Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6799","DOI":"10.1093\/nar\/gkv656","article-title":"Transcriptomic profiling of gene expression and RNA processing during Leishmania major differentiation","volume":"43","author":"Dillon","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/mmi.13375","article-title":"Conditional gene deletion with DiCre demonstrates an essential role for CRK3 in Leishmania mexicana cell cycle regulation","volume":"100","author":"Duncan","year":"2016","journal-title":"Mol. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3390\/microorganisms9040691","article-title":"Leishmania protein kinases: important regulators of the parasite life cycle and molecular targets for treating leishmaniasis","volume":"9","author":"Efstathiou","year":"2021","journal-title":"Microorganisms"},{"key":"B20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0166-6851(94)90133-3","article-title":"Pyruvate kinase of Leishmania mexicana mexicana. Cloning and analysis of the gene, overexpression in Escherichia coli and characterization of the enzyme","volume":"64","author":"Ernest","year":"1994","journal-title":"Mol. Biochem. Parasitol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1005186","DOI":"10.1371\/journal.ppat.1005186","article-title":"Comparative life cycle transcriptomics revises Leishmania mexicana genome annotation and links a chromosome duplication with parasitism of vertebrates","volume":"11","author":"Fiebig","year":"2015","journal-title":"PLoS Pathog."},{"key":"B22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/B978-0-12-800280-3.00009-8","article-title":"Application of activity-based protein profiling to study enzyme function in adipocytes","volume":"538","author":"Galmozzi","year":"2014","journal-title":"Methods Enzymol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1021\/acschembio.2c00633","article-title":"Profiling Sulfur(VI) fluorides as reactive functionalities for chemical biology tools and expansion of the ligandable proteome","volume":"18","author":"Gilbert","year":"2023","journal-title":"ACS Chem. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.str.2012.07.005","article-title":"The crystal structure of the MAP kinase LmaMPK10 from Leishmania major reveals parasite-specific features and regulatory mechanisms","volume":"20","author":"Horjales","year":"2012","journal-title":"Structure"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e00029","DOI":"10.1128\/mBio.00029-17","article-title":"The transcriptome of Leishmania major developmental stages in their natural sand fly vector","volume":"8","author":"Inbar","year":"2017","journal-title":"mBio"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e202500160","DOI":"10.1002\/cbic.202500160","article-title":"Profiling serine hydrolases in the Leishmania host-pathogen interactome using cell-permeable activity-based fluorophosphonate probes","volume":"26","author":"Isern","year":"2025","journal-title":"Chembiochem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1003886","DOI":"10.1371\/journal.ppat.1003886","article-title":"Regulators of Trypanosoma brucei cell cycle progression and differentiation identified using a kinome-wide RNAi screen","volume":"10","author":"Jones","year":"2014","journal-title":"PLoS Pathog."},{"key":"B28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1021\/acsinfecdis.7b00244","article-title":"Genetically validated drug targets in leishmania: current knowledge and future prospects","volume":"4","author":"Jones","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cbpa.2019.10.007","article-title":"Activity-based protein profiling in bacteria: applications for identification of therapeutic targets and characterization of microbial communities","volume":"54","author":"Keller","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nchembio.1582","article-title":"A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors","volume":"10","author":"Lanning","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.tibs.2018.01.006","article-title":"Metabolic kinases moonlighting as protein kinases","volume":"43","author":"Lu","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.tplants.2012.05.010","article-title":"ABC1K atypical kinases in plants: filling the organellar kinase void","volume":"17","author":"Lundquist","year":"2012","journal-title":"Trends Plant Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.1021\/ac303478g","article-title":"Mass spectrometry based method to increase throughput for kinome analyses using ATP probes","volume":"85","author":"McAllister","year":"2013","journal-title":"Anal. Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"11280","DOI":"10.1021\/cr500197d","article-title":"Kinases as druggable targets in trypanosomatid protozoan parasites","volume":"114","author":"Merritt","year":"2014","journal-title":"Chem. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/pmic.200700697","article-title":"Phosphoproteomic analysis of Leishmania donovani pro- and amastigote stages","volume":"8","author":"Morales","year":"2008","journal-title":"Proteomics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1128\/EC.00196-09","article-title":"Leishmania major MPK7 protein kinase activity inhibits intracellular growth of the pathogenic amastigote stage","volume":"9","author":"Morales","year":"2010","journal-title":"Eukaryot. Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"12892","DOI":"10.1074\/jbc.M109.079905","article-title":"Allosteric mechanism of pyruvate kinase from Leishmania mexicana uses a rock and lock model","volume":"285","author":"Morgan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.3324\/haematol.2018.193391","article-title":"Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI","volume":"103","author":"Nicolson","year":"2018","journal-title":"Haematologica"},{"key":"B39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1471-2164-6-127","article-title":"Comparative analysis of the kinomes of three pathogenic trypanosomatids: leishmania major, Trypanosoma brucei and Trypanosoma cruzi","volume":"6","author":"Parsons","year":"2005","journal-title":"BMC Genom."},{"key":"B40","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1021\/bi062142x","article-title":"Functional interrogation of the kinome using nucleotide acyl phosphates","volume":"46","author":"Patricelli","year":"2007","journal-title":"Biochemistry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"639","DOI":"10.34172\/apb.2023.082","article-title":"Mapping the evolution of activity-based protein profiling: a bibliometric review","volume":"13","author":"Porta","year":"2023","journal-title":"Adv. Pharm. Bull."},{"key":"B42","doi-asserted-by":"publisher","first-page":"100164","DOI":"10.1016\/j.crphar.2023.100164","article-title":"Activity-based protein profiling: a graphical review","volume":"5","author":"Porta","year":"2023","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"B43","doi-asserted-by":"publisher","first-page":"929493","DOI":"10.3389\/fphar.2022.929493","article-title":"Discovery of Leishmania druggable serine proteases by activity-based protein profiling","volume":"13","author":"Porta","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e02960","DOI":"10.1128\/spectrum.02960-23","article-title":"Inhibition of HSP90 distinctively modulates the global phosphoproteome of Leishmania mexicana developmental stages","volume":"11","author":"Porta","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"B45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-1-0716-4502-4_6","article-title":"Microplate-Based enzymatic activity assay protocol powered by activity-based probes","volume":"2921","author":"Porta","year":"2025","journal-title":"Methods Mol. Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1128\/AAC.02022-13","article-title":"Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection","volume":"58","author":"Rachidi","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e201900603","DOI":"10.26508\/lsa.201900603","article-title":"Phenotypic proteomic profiling identifies a landscape of targets for circadian clock-modulating compounds","volume":"2","author":"Ray","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"B48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.phrs.2016.09.011","article-title":"Ibrutinib inhibition of Bruton protein-tyrosine kinase (BTK) in the treatment of B cell neoplasms","volume":"113","author":"Roskoski","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1093\/jac\/dku069","article-title":"Activity of anti-cancer protein kinase inhibitors against Leishmania spp","volume":"69","author":"Sanderson","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/pro.3691","article-title":"An overview of structure, function, and regulation of pyruvate kinases","volume":"28","author":"Schormann","year":"2019","journal-title":"Protein Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1021\/acs.jmedchem.1c00980","article-title":"Chemical probes for understudied kinases: challenges and opportunities","volume":"65","author":"Serafim","year":"2022","journal-title":"J. Med. Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"916232","DOI":"10.3389\/fmolb.2022.916232","article-title":"The protein kinase CK1: inhibition, activation, and possible allosteric modulation","volume":"9","author":"Sunkari","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat. Methods."},{"key":"B54","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s13071-017-2379-y","article-title":"Identification of a RAC\/AKT-like gene in Leishmania parasites as a putative therapeutic target in leishmaniasis","volume":"10","author":"Varela-M","year":"2017","journal-title":"Parasit. Vectors"},{"key":"B55","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.ijpara.2010.02.004","article-title":"LmxMPK4, an essential mitogen-activated protein kinase of Leishmania mexicana is phosphorylated and activated by the STE7-like protein kinase LmxMKK5","volume":"40","author":"von Freyend","year":"2010","journal-title":"Int. J. Parasitol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e202419736","DOI":"10.1002\/anie.202419736","article-title":"Probing the protein kinases' cysteinome by covalent fragments","volume":"64","author":"Wang","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1093\/emboj\/17.9.2619","article-title":"A mitogen-activated protein (MAP) kinase homologue of Leishmania mexicana is essential for parasite survival in the infected host","volume":"17","author":"Wiese","year":"1998","journal-title":"EMBO J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.ijpara.2007.04.008","article-title":"Leishmania MAP kinases--familiar proteins in an unusual context","volume":"37","author":"Wiese","year":"2007","journal-title":"Inter. J. Parasitol."},{"key":"B59","unstructured":"Leishmaniasis\n          \n          \n          2023"},{"key":"B60","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41586-018-0356-z","article-title":"Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis","volume":"560","author":"Wyllie","year":"2018","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1021\/acs.jmedchem.6b01815","article-title":"Determining cysteines available for covalent inhibition across the human kinome","volume":"60","author":"Zhao","year":"2017","journal-title":"J. Med. Chem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1687590\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:43:29Z","timestamp":1767681809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1687590\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":61,"alternative-id":["10.3389\/fphar.2025.1687590"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1687590","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2025-zg4jj","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"article-number":"1687590"}}